Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Paradigm IV Trial - PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness

NCT00529945 is registered in ClinicalTrials.gov with Cierra as lead sponsor.

NCT NCT00529945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00529945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Paradigm IV Trial - PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness
Lead sponsor
Cierra
Phase
Not applicable
Overall status
Suspended
Start date
August 31, 2007
Completion date
December 31, 2007
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decompression illness, migraine, pfo, stroke, transient ischemic attack